 |
PORT VILA, Vanuatu, May 22, 2025 /PRNewswire/ -- Vantage Markets, a leading multi-asset broker, has been awarded "Best Online Trading Platform APAC" at the prestigious Global Business Magazine Awards 2025. This recognition highlights Vantage's commitment to delivering cutting-edge trading solutions, innovative financial tools and exceptional customer service to traders.
The Global Business Magazine Awards celebrate business innovators, market disruptors, and industry leaders worldwide. Organised by Global Business Magazine LLC, the awards honour top-performing B2B and B2C companies that excel in customer service and market innovation. The selection process is entirely merit-based, ensuring that winners are recognised purely for their excellence and impact in their respective industries.
Marc Despallieres, CEO of Vantage Markets, commented on the achievement: "We are honoured to receive this prestigious award, which reflects our relentless focus on empowering traders with a seamless, secure, and technologically advanced trading experience. At Vantage, we continuously strive to push the boundaries of innovation while maintaining our client-first approach. This recognition is a testament to the hard work of our team and the trust our clients place in us."
As the brokerage industry evolves rapidly, Vantage has distinguished itself through user-friendly platforms, competitive pricing, robust security measures, and educational resources that cater to both beginner and advanced traders. Winning this award reinforces Vantage's position as a trusted leader in the financial markets.
Visit Vantage Markets website, for more information about Vantage's award-winning services and upcoming initiatives.
About Global Business Magazine Awards
The Global Business Magazine Awards recognise excellence across various industries, from fintech and blockchain to brokerage and beyond. The awards highlight organisations that drive market disruption while delivering outstanding value to customers. The selection process is free of cost, ensuring an unbiased celebration of true industry leaders.
About Vantage
Vantage Markets (or Vantage) is a multi-asset CFD broker offering clients access to a nimble and powerful service for trading Contracts for Difference (CFDs) products, including Forex, Commodities, Indices, Shares, ETFs, and Bonds.
With over 15 years of market experience, Vantage transcends the role of broker, providing a reliable trading platform, an award-winning mobile trading app, and a user-friendly trading platform that provide clients access to trading opportunities.
trade smarter @vantage
RISK WARNING: CFDs are complex instruments and carry a high risk of losing money rapidly due to leverage. Ensure you understand the risks before trading.
Disclaimer: This article is provided for informational purposes only and does not constitute financial advice, an offer, or solicitation of any financial products or services. The content is not intended for residents of any jurisdiction where such distribution or use would be contrary to local law or regulation. Readers are advised to seek independent professional advice before making any investment or financial decisions. Any reliance you place on the information presented is strictly at your own risk.
Photo - https://mma.prnasia.com/media2/2694101/Vantage_Wins_Best_Online_Trading_Platform_APAC_Global_Business_Magazine.jpg?p=medium600
Logo - https://mma.prnasia.com/media2/2506103/Vantage_15_Logo_Logo.jpg?p=medium600
PORT VILA, Vanuatu, May 22, 2025 /PRNewswire/ -- Vantage Markets, a leading multi-asset broker, has been awarded "Best Online Trading Platform APAC" at the prestigious Global Business Magazine Awards 2025. This recognition highlights Vantage's commitment to delivering cutting-edge trading solutions, innovative financial tools and exceptional customer service to traders.
The Global Business Magazine Awards celebrate business innovators, market disruptors, and industry leaders worldwide. Organised by Global Business Magazine LLC, the awards honour top-performing B2B and B2C companies that excel in customer service and market innovation. The selection process is entirely merit-based, ensuring that winners are recognised purely for their excellence and impact in their respective industries.
Marc Despallieres, CEO of Vantage Markets, commented on the achievement: "We are honoured to receive this prestigious award, which reflects our relentless focus on empowering traders with a seamless, secure, and technologically advanced trading experience. At Vantage, we continuously strive to push the boundaries of innovation while maintaining our client-first approach. This recognition is a testament to the hard work of our team and the trust our clients place in us."
As the brokerage industry evolves rapidly, Vantage has distinguished itself through user-friendly platforms, competitive pricing, robust security measures, and educational resources that cater to both beginner and advanced traders. Winning this award reinforces Vantage's position as a trusted leader in the financial markets.
Visit Vantage Markets website, for more information about Vantage's award-winning services and upcoming initiatives.
About Global Business Magazine Awards
The Global Business Magazine Awards recognise excellence across various industries, from fintech and blockchain to brokerage and beyond. The awards highlight organisations that drive market disruption while delivering outstanding value to customers. The selection process is free of cost, ensuring an unbiased celebration of true industry leaders.
About Vantage
Vantage Markets (or Vantage) is a multi-asset CFD broker offering clients access to a nimble and powerful service for trading Contracts for Difference (CFDs) products, including Forex, Commodities, Indices, Shares, ETFs, and Bonds.
With over 15 years of market experience, Vantage transcends the role of broker, providing a reliable trading platform, an award-winning mobile trading app, and a user-friendly trading platform that provide clients access to trading opportunities.
trade smarter @vantage
RISK WARNING: CFDs are complex instruments and carry a high risk of losing money rapidly due to leverage. Ensure you understand the risks before trading.
Disclaimer: This article is provided for informational purposes only and does not constitute financial advice, an offer, or solicitation of any financial products or services. The content is not intended for residents of any jurisdiction where such distribution or use would be contrary to local law or regulation. Readers are advised to seek independent professional advice before making any investment or financial decisions. Any reliance you place on the information presented is strictly at your own risk.
Photo - https://mma.prnasia.com/media2/2694101/Vantage_Wins_Best_Online_Trading_Platform_APAC_Global_Business_Magazine.jpg?p=medium600
Logo - https://mma.prnasia.com/media2/2506103/Vantage_15_Logo_Logo.jpg?p=medium600
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Vantage Wins "Best Online Trading Platform APAC" at the Global Business Magazine Awards 2025
T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors
Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer
Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. Accounts advised by T. Rowe Price Investment Management, Inc. and Braidwell LP joined the financing as new investors. Existing investors, including Illumina Ventures and Sands Capital, also participated. The financing will support the continued commercial advancement of Alamar's precision proteomics platform.
"We deeply appreciate the continued support from our existing investors and are excited to welcome our new partners," said Dr. Yuling Luo, founder, chairman, and chief executive officer of Alamar. "Their confidence in our vision and strategy underscores the transformative potential of our work. This investment will enable us to accelerate innovation and continue to expand the reach of our platform, unlocking the full value of precision medicine and early disease detection."
Leadership and Board Expansion
Alamar also announced key additions to its executive leadership team and board of directors to support the company's continued growth and commitment to operational excellence.
To further strengthen its scientific leadership, Alamar welcomes Dr. Stephen Williams as Chief Scientific Officer. Steve brings more than three decades of experience in precision medicine and biomarker innovation. He most recently served as Chief Medical Officer at Standard BioTools and SomaLogic, and previously spent 18 years at Pfizer in senior leadership roles. A recognized leader in the scientific community, he has served on the NIH National Advisory Council for Biomedical Imaging and Bioengineering, helped launch the Alzheimer's Disease Neuroimaging Initiative, and co-founded the FDA-FNIH-PhRMA Biomarker Consortium.
Alamar has also appointed Rebecca Chambers and Dr. Frank Witney as directors to its board. Rebecca, Chief Financial Officer at Veracyte, brings deep financial and healthcare leadership experience from her current role as well as previous positions at Outset Medical, Illumina, Myriad Genetics and Life Technologies. Frank, an operating partner at Ampersand Capital Partners, adds over three decades of life sciences leadership experience, including serving as President and CEO of Affymetrix and Dionex Corporation, and currently sits on the boards of Revvity, Cerus Corporation, Standard BioTools, and several private companies.
"I am thrilled to welcome Steve to our leadership team, and Rebecca and Frank to our board of directors," said Dr. Yuling Luo. "Their deep expertise and diverse perspectives will be invaluable as we accelerate our mission to unleash the power of our Precision Proteomics platform, to enable broad impacts across health and disease. This is an exciting moment for Alamar, and we look forward to the impact their leadership will have on driving innovation and growth."
About Alamar Biosciences, Inc.
Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
